Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades Edwards Lifesciences to Market Perform

Raymond James Downgrades Edwards Lifesciences to Market Perform

Raymond James analyst Jayson Bedford downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Market Perform.

byBenzinga Newsdesk

February 6, 2023

1 minute read

Raymond James analyst Jayson Bedford downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Market Perform.

Analyst Ratings

Where Intuit Stands With Analysts

By Benzinga Insights

November 27, 3:00 PM

Analysts have provided the following ratings for Intuit (NASDAQ:INTU) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

INTU

Zoom Ups Competition With Microsoft, Throws In AI and Google Doc Like Features In Bundled Offering

By Anusuya Lahiri

October 4, 7:25 AM

Zoom Video Communications, Inc (NASDAQ: ZM) unveiled a series of AI-powered innovations at Zoomtopia 2023, significantly enhancing collaborative and communication tools for the modern workspace.

GOOGL

Raymond James Maintains Outperform on Gossamer Bio, Raises Price Target to $14

By Benzinga Newsdesk

July 14, 4:33 AM

Raymond James analyst Steven Seedhouse maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $10 to $14.

GOSS

Gold Falls Sharply; US Composite PMI Surges In May

By Avi Kapoor

May 23, 12:01 PM

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 250 points on…

BCYC

Raymond James Downgrades Edwards Lifesciences to Market Perform

Related Posts

Where Intuit Stands With Analysts

Zoom Ups Competition With Microsoft, Throws In AI and Google Doc Like Features In Bundled Offering

Raymond James Maintains Outperform on Gossamer Bio, Raises Price Target to $14

Gold Falls Sharply; US Composite PMI Surges In May